Loading the company…
Loading the company…
Families: Skin substitutes & wound grafts, Bone graft & orthobiologics, Lumbar fusion.
All companies · Product and company coverage
In the last ten years FDA made 4 decisions for Acro Biomedical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2024 (1). The latest was on 2024-10-18.
| Family | Decisions on record |
|---|---|
| Skin substitutes & wound grafts | 2 |
| Bone graft & orthobiologics | 2 |
| Lumbar fusion | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2024-10-18 | 510(k) | K233378 | ABCcolla® Collagen ADM Scaffold |
| 2021-10-08 | 510(k) | K212156 | ABCcolla Bone Matrix |
| 2018-02-01 | 510(k) | K171629 | ABCcolla Bone Graft |
| 2017-05-10 | 510(k) | K162348 | ABCcolla Collagen Matrix |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Acro Biomedical.